Oragenics Inc (OGEN)
1.16
+0.03
(+2.65%)
USD |
NYAM |
Apr 19, 16:00
1.13
-0.03
(-2.59%)
After-Hours: 20:00
Oragenics Cash from Financing (TTM): 0.2839M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.2839M |
September 30, 2023 | 0.3765M |
June 30, 2023 | -0.4591M |
March 31, 2023 | -0.4734M |
December 31, 2022 | -0.4949M |
September 30, 2022 | -1.186M |
June 30, 2022 | -0.5042M |
March 31, 2022 | -0.2297M |
December 31, 2021 | 23.14M |
September 30, 2021 | 35.15M |
June 30, 2021 | 39.65M |
March 31, 2021 | 39.59M |
December 31, 2020 | 16.32M |
September 30, 2020 | 5.023M |
June 30, 2020 | -0.1068M |
Date | Value |
---|---|
March 31, 2020 | -0.3266M |
December 31, 2019 | 11.10M |
September 30, 2019 | 20.61M |
June 30, 2019 | 33.05M |
March 31, 2019 | 34.64M |
December 31, 2018 | 23.25M |
September 30, 2018 | 18.41M |
June 30, 2018 | 8.197M |
March 31, 2018 | 8.413M |
December 31, 2017 | 8.449M |
September 30, 2017 | 4.787M |
June 30, 2017 | 3.563M |
March 31, 2017 | 4.480M |
December 31, 2016 | 4.452M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.186M
Minimum
Sep 2022
39.65M
Maximum
Jun 2021
11.61M
Average
0.3765M
Median
Sep 2023
Cash from Financing (TTM) Benchmarks
Palatin Technologies Inc | 5.553M |
Inogen Inc | 0.96M |
Cyclacel Pharmaceuticals Inc | 0.848M |
Actinium Pharmaceuticals Inc | 14.87M |
MAIA Biotechnology Inc | 9.271M |